Renal failure Flashcards

1
Q

5 kidney functions

A
  • Fluid/electrolyte balance
  • Waste product excretion
  • Acid/base balance
  • EPO synthesis
  • Vitamin D activation (calcitriol)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CKD: presentation

a) Usually diagnosed how?
b) Who should be screened?
c) Possible symptoms
d) Possible signs

A

a) Incidental U+E (eGFR), urine dip (proteinuria) or ACR

b) Anyone with history of:
- AKI, structural renal disease, recurrent stones, or BPH
- Diabetes, HTN, CVD, multisystem disease (eg, SLE)
- FHx of ESRF or familial renal disease

c) Usually only with severe CKD:
- Uraemic symptoms: anorexia, nausea, vomiting, muscle cramps, pruritus, headache, confusion
- Anaemic symptoms: lethargy, dyspnoea, pallor
- Overload: peripheral and pulmonary oedema

d) - Uraemia: excoriation,
- Anaemia: pallor
- Overload: oedema, effusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CKD: investigations

a) Diagnostic tests
b) Bloods - tests plus possible findings
c) Other (eg. antibodies, imaging, special tests)

A

a) eGFR (blood) and ACR (urine)

b) - FBC: anaemia of chronic disease
- Glucose (DM) and cholesterol (dyslipidaemia)
- Electrolytes: Na+ (low), K+ (raised), bicarbonate (low)
- Bone profile: Ca2+ (low), Pi (high), Alk Phos (high), PTH (high), albumin (low)

c) - Antibodies: ANA, ANCA, anti-GBM, complement, Hep B/HIV serology
- Imaging: USS kidneys, CT KUB (stones)
- Special tests: myeloma screen, urine microscopy, renal biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic kidney disease (CKD).

a) Define
b) Staging
c) Define ‘renal failure’
d) Causes of CKD (3 big ones)

A

a) Albuminuria or eGFR < 60 for 3 months or more

b) Stages of CKD.
1: eGFR > 90 (with albuminuria)
2: 60 - 89 (with albuminuria)
3a: 45 - 59
3b: 30 - 44
4: 15 - 29
5: < 15 (ESRF)
(usually require dialysis at eGFR ~ 7)

c) Failure is one or more of:
- eGFR < 15
- Need for dialysis or transplantation

d) - Big ones: diabetes, HTN, old age
- Others: renovascular disease, GN, pyelonephritis, chronic NSAID use, myeloma, vasculitis, obstructive nephropathy, familial (eg. PKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Anaemia in CKD.

a) Causes
b) Management

A

a) - Iron deficiency (due to increased hepcidin levels, which inhibits iron absorption from the gut)
- Reduced EPO

b) IV iron (bypasses GI route), +/- EPO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

CKD management.

a) Non-drug
b) Drugs
c) Monitoring

A

a) - Patient education
- Encourage exercise, weight loss, reduced alcohol and smoking cessation
- Dietary (if indicated): fluid and salt restrict, potassium and phosphate restrict, protein increase
- Control risk factors: DM, HTN, cholesterol, etc.
- Avoid nephrotoxic medication if possible (eg. NSAIDs, aminoglycosides, radiocontrast)

b) - Statin in all CKD for primary/secondary prevention
- ACE if: hypertensive, diabetic or proteinuric
- Immunisations - pneumococcal, annual influenza
- Bone protection: vitamin D, Ca2+, (+/- bisphosphonates)
- Phosphate binders

c) - Monitor eGFR, U+Es and proteinuria
- Monitor BP, glucose and other risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Renal replacement therapy (RRT).

a) Types
b) eGFR threshold

A

a) Haemodialysis - 3x per week for 4h
Peritoneal dialysis

b) eGFR ~ 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PD peritonitis.

a) Clinical fx

A

a) Cloudly PD effluent, pyrexia, abdominal pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peritoneal dialysis.

a) Advantages
b) Contraindications
c) Problems

A

a) Independence, fewer restrictions on diet and fluid intake
b) Need residual kidney function (20% in one kidney), stomas
c) Problems - PD peritonitis (aseptic technique vital), only lasts a few years due to peritoneal scarring (then need HD/transplant), weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AV fistula.

a) Signs o/e
b) What is a fistula? What is an AV fistula?
c) Alternative to fistulae

A

a) Thrill (palpable) and bruit (auscultated)

b) - Connection between 2 endothelial surfaces
- Arterio-venous anastomosis

c) - AV graft
- Femoral line (lasts 7 days)
- CVC/ tunnelled line
- PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Haemodialysis: problems and management

A
  • Hypotension (headache, dizzy, nausea, reduced GCS) - managed with head down, feet up +/- fluids (don’t take BP meds on dialysis day)
  • Cramps
  • Strain on the heart
  • Infection in the line
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AKI: define

A
  1. ≥ 26.4 increase in serum creatinine over 48 hours, or
  2. ≥ 50% increase in serum creatinine over 7 days, or
  3. < 0.5 ml/kg/h urine output* for more than 6 hours
    * urine output is more sensitive than creatinine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

AKI: causes

a) Risk factors (renal, other, drugs)
b) Pre-renal (90%)
c) Renal
d) Post-renal

A

a) - General: elderly, diabetes, CVD, HTN,
- Renal: CKD, history of AKI, renal stones
- Drugs: NSAIDs, ACE/ARB, diuretics, aminoglycosides

b) - Hypotension/shock (sepsis, cardiogenic, etc.)
- Hypovolaemia (dehydration, vomiting, diarrhoea, burns, inappropriate diuresis)
- Overloaded states - CCF, cirrhosis, CKD
- Renovascular - RAS, CCF, NSAIDs, ACE/ARB

c) - Glomerulonephritis
- ATN: prolonged ischaemia, nephrotoxins (eg myoglobin, aminoglycosides, radiocontrast, myeloma protein)
- AIN: NSAIDs, infection, autoimmune (eg. SLE)

d) Obstructive: BPH/prostate Ca, stones, stricture, pelvic/ bladder Ca, neurogenic bladder, retroperitoneal fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AKI: assessment and investigations

a) Pertinent points in the history
b) Examination
c) Investigations

A

a) - HPC - vomiting, diarrhoea, fever, haematuria, obstructive symptoms, etc.
- PMHx - diabetes, HTN, CVD, kidney stones, BPH, etc.

b) - Signs of sepsis / shock
- Fluid status - overload (CCF), dehydrated (pre-renal)
- Abdomen - distended bladder (?post-renal - BPH)

c) - Bedside: urine dip (protein, blood, infection, casts)
- Bloods: FBC (infection, eosinophilia in AIN), CRP/ESR, U+E, clotting (DIC), CK (rhabdo),
- Imaging: USS (obstruction), AXR/CT (stones), CXR (pulmonary oedema)
- Special tests: antibodies (ANA, ANCA, etc.), myeloma protein electrophoresis, renal biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AKI: management

a) Principles
b) Specific drugs to stop/avoid
c) Fluid balance
d) Electrolyte balance
e) Specific interventions that may help
f) Indications for dialysis
g) Best treatment is…?

A

a) - Treat the underlying cause
- Stop/reduce any precipitating factors (eg. NSAIDs)
- Optimise fluid and electrolyte status

b) - NSAIDs, aminoglycosides, contrast media
- ACE, ARB, diuretics (if hypovolaemic; if overloaded - may need to continue or increase diuresis)
- Swap other drugs (eg. morphine to oxycodone)

c) - If dehydrated - increase fluids (beware overload)
- If overloaded - restrict fluids and consider diuretics
- Monitor urine output and use fluid balance chart

d) - Potassium (K+) - may need restricting; consider insulin/dex, calcium resonium (Ca-Gluc if ECG changes)
- Phosphate, urea etc. may build up - monitor
- Bicarbonate, calcium, glucose - may deplete - monitor

e) - Sepsis - antibiotics
- GN/autoimmune - steroids, etc.
- Obstruction - catheterise, remove stone, nephrostomy, BPH management (medical, surgical)

f) AEIOU.
- Acidosis (metabolic acidosis, pH < 7.2, refractory to Rx)
- Electrolytes (K+ > 6.5 refractory to medical Rx)
- Intoxication
- Overload (pulmonary oedema, refractory to medical Rx)
- Uraemic pericarditis/encephalopathy

g) Prevention!
- identify at risk patients and manage risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patient has been admitted with AKI. For each of the following drugs, would you: Continue, Stop, Increase dose or Reduce dose?

a) Dalteparin 5000 units (prophylactic dose)
b) Dalteparin 50,000 units (PE treatment)
c) Furosemide 40 mg od
d) Amlodipine 5 mg od
e) Gentamicin 80 mg od
f) Diclofenac 50 mg tds
g) Phenytoin 300 mg bd
h) Morphine sulphate 20 mg bd
i) Aciclovir 800 mg 5x/day
j) Flucloxacillin 2g qds (treatment for endocarditis - hence big dose for tissue penetration)
k) Prednisolone 5 mg od (long term for PMR)
l) Ramipril 10 mg od

  • Note: in hepatic/renal dysfunction, you can reduce the dose and still maintain the same therapeutic levels due to accumulation
A

a) eGFR < 20: half the dose of LMWH (or give an IV infusion of UFH); check APTT in 4 - 6 hours
b) As before
c) Depends on fluid status: if hypervolaemic may continue or increase; if hypovolaemic - stop
d) Depends on BP/extent of angina

e) Nephrotoxic: swap to something else treating gram-negative infection (eg. cephalosporins, tazocin, meropenem)
- note: metronidazole treats anaerobes only

f) Stop
g) Hepatic excretion (fat soluble - as for most drugs that cross the BBB; and HIV medications)
h) Switch to fentany 72h patchl/ oxycodone
i) Reduce
j) Reduce
k) Increase to 10 mg (around physiological dose)
l) Stop

17
Q

ACE inhibitors.

a) CV indications
b) Indication in CKD
c) Effect on eGFR

A

a) HTN, HF, post-MI, post-stroke
b) Proteinuria (mostly diabetic)

c) Initial drop (hence bad in AKI); especially in renovascular disease (consider if they have: bruit, one small kidney on USS, resistant HTN, CVD/PAD)
- Then a slower eGFR decline relative to those not on ACE (hence good in CKD)

18
Q

eGFR

  • why is it more useful than creatinine in CKD?
  • when can it not be used to assess renal function?
A

a) Accounts for age, gender and race; which corrects for muscle mass effects on creatinine levels
b) AKI

19
Q

Protein collection.

a) Modern way to assess
c) Old way to assess
c) Why is urine dipstick flawed?

A

a) ACR: albumin-creatinine ratio
b) 24-hour collection
c) Tells you the concentration of protein, not the volume (affected by hydration levels/urine output)

20
Q

Contrast nephropathy.

a) when does creatinine peak?
b) management

A

a) After 72 hours

b) - Avoid radiocontrast in at-risk patients if possible
- If required, optimal pre-hydration: IV volume expansion with isotonic sodium bicarbonate or 0.9% NaCl

21
Q

PKD.

a) Genetics
b) Clinical features
c) Investigations
d) Management

A

a) - Mostly autosomal dominant (present in adulthood): PKD 1 (chromosome 16) and PKD 2 (chromosome 4)
- Autosomal recessive PKD usually presents in infancy

b) - Renal cysts - haematuria, loin pain, loin mass, HTN, recurrent UTI, chronic renal failure + need for dialysis/ transplant
- Cysts in the liver, pancreas, spleen and ovaries
- Berry aneurysms and SAH
- Mitral valve prolapse

c) - Diagnosed with renal USS

d) - Manage HTN
- Monitor UEs/creatinine (eGFR) and BP
- Regular follow-up in renal outpatients
- ESRF: require dialysis or transplantation
- Genetic counselling and testing offered